Armstrong AJ, Halabi S, Luo J, et al. The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E). J Clin Oncol 36, 2018 (suppl; abstr 5004).
Toename behandelopties voor subgroep met HER2-positief coloncarcinoom
sep 2023 | Maag-darm-leveroncologie